Peakstone Realty Trust outlines 70% mark-to-market opportunity in IOS portfolio for 2025 growth
Q4 2024 Management View Mike Escalante, President and CEO, highlighted the company's strategic pivot toward industrial assets, now comprising nearly 40% of total ABR, up from 25% at the beginning of ...
Prothena outlines potential multi-billion dollar opportunity with birtamimab launch by 2026
Q4 2024 Management View Gene Kinney, President and CEO, emphasized Prothena's focus on addressing significant unmet medical needs through its portfolio of therapies targeting neurodegenerative and ...